Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1965 1
1967 3
1968 2
1969 2
1971 3
1972 5
1973 2
1974 1
1975 3
1976 4
1977 4
1978 5
1979 8
1980 4
1981 5
1982 5
1983 10
1984 9
1985 9
1986 15
1987 20
1988 13
1989 16
1990 32
1991 29
1992 32
1993 26
1994 34
1995 45
1996 34
1997 34
1998 46
1999 54
2000 53
2001 62
2002 62
2003 58
2004 81
2005 112
2006 115
2007 128
2008 121
2009 147
2010 174
2011 202
2012 220
2013 242
2014 275
2015 265
2016 279
2017 348
2018 338
2019 431
2020 572
2021 660
2022 677
2023 662
2024 800
2025 320

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,115 results

Results by year

Filters applied: . Clear all
Page 1
NRF2, a Superstar of Ferroptosis.
Yan R, Lin B, Jin W, Tang L, Hu S, Cai R. Yan R, et al. Among authors: lin b. Antioxidants (Basel). 2023 Sep 8;12(9):1739. doi: 10.3390/antiox12091739. Antioxidants (Basel). 2023. PMID: 37760042 Free PMC article. Review.
Upregulation of PD-L1 in Senescence and Aging.
Onorati A, Havas AP, Lin B, Rajagopal J, Sen P, Adams PD, Dou Z. Onorati A, et al. Among authors: lin b. Mol Cell Biol. 2022 Oct 20;42(10):e0017122. doi: 10.1128/mcb.00171-22. Epub 2022 Sep 26. Mol Cell Biol. 2022. PMID: 36154662 Free PMC article.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. Among authors: lin b. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes.
Guo JL, Braun D, Fitzgerald GA, Hsieh YT, Rougé L, Litvinchuk A, Steffek M, Propson NE, Heffner CM, Discenza C, Han SJ, Rana A, Skuja LL, Lin BQ, Sun EW, Davis SS, Balasundar S, Becerra I, Dugas JC, Ha C, Hsiao-Nakamoto J, Huang F, Jain S, Kung JE, Liau NPD, Mahon CS, Nguyen HN, Nguyen N, Samaddar M, Shi Y, Tatarakis D, Tian Y, Zhu Y, Suh JH, Sandmann T, Calvert MEK, Arguello A, Kane LA, Lewcock JW, Holtzman DM, Koth CM, Di Paolo G. Guo JL, et al. Among authors: lin bq. Cell. 2025 Jan 9;188(1):187-206.e26. doi: 10.1016/j.cell.2024.10.027. Epub 2024 Nov 11. Cell. 2025. PMID: 39532095 Free article.
Expert consensus statement on therapeutic drug monitoring and individualization of linezolid.
Lin B, Hu Y, Xu P, Xu T, Chen C, He L, Zhou M, Chen Z, Zhang C, Yu X, Fang L, Zhu J, Ji Y, Lin Q, Cao H, Dai Y, Lu X, Shi C, Li L, Wang C, Li X, Fang Q, Miao J, Zhu Z, Lin G, Zhan H, Lv S, Zhu Y, Cai X, Ying Y, Chen M, Xu Q, Zhang Y, Xu Y, Federico P, Jiang S, Dai H. Lin B, et al. Front Public Health. 2022 Aug 10;10:967311. doi: 10.3389/fpubh.2022.967311. eCollection 2022. Front Public Health. 2022. PMID: 36033811 Free PMC article.
Integrated proteomic and transcriptomic landscape of macrophages in mouse tissues.
Qie J, Liu Y, Wang Y, Zhang F, Qin Z, Tian S, Liu M, Li K, Shi W, Song L, Sun M, Tong Y, Hu P, Gong T, Wang X, Huang Y, Lin B, Zheng X, Zhou R, Lv J, Du C, Wang Y, Qin J, Yang W, He F, Ding C. Qie J, et al. Among authors: lin b. Nat Commun. 2022 Nov 30;13(1):7389. doi: 10.1038/s41467-022-35095-7. Nat Commun. 2022. PMID: 36450731 Free PMC article.
Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex.
Shirai T, Nakai A, Ando E, Fujimoto J, Leach S, Arimori T, Higo D, van Eerden FJ, Tulyeu J, Liu YC, Okuzaki D, Murayama MA, Miyata H, Nunomura K, Lin B, Tani A, Kumanogoh A, Ikawa M, Wing JB, Standley DM, Takagi J, Suzuki K. Shirai T, et al. Among authors: lin b. Sci Immunol. 2023 Mar 31;8(81):eadc9324. doi: 10.1126/sciimmunol.adc9324. Epub 2023 Mar 31. Sci Immunol. 2023. PMID: 37000855
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.
Reyes Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XHT, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME. Reyes Gaido OE, et al. Among authors: lin bl. Sci Transl Med. 2023 Jun 21;15(701):eabq7839. doi: 10.1126/scitranslmed.abq7839. Epub 2023 Jun 21. Sci Transl Med. 2023. PMID: 37343080 Free PMC article.
Anti-PD-1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2-Positive Gastric Cancer through Gasdermin B-Cleavage Induced Pyroptosis.
Lin W, Zhang Y, Yang Y, Lin B, Zhu M, Xu J, Chen Y, Wu W, Chen B, Chen X, Liu J, Wang H, Teng F, Yu X, Wang H, Lu J, Zhou Q, Teng L. Lin W, et al. Among authors: lin b. Adv Sci (Weinh). 2023 Oct;10(30):e2303908. doi: 10.1002/advs.202303908. Epub 2023 Aug 16. Adv Sci (Weinh). 2023. PMID: 37587833 Free PMC article.
7,115 results